191 related articles for article (PubMed ID: 22927238)
41. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.
Li D; Li T; Wang F; Tian H; Samuels HH
Mol Cell Biol; 2002 Aug; 22(16):5782-92. PubMed ID: 12138189
[TBL] [Abstract][Full Text] [Related]
42. Bexarotene ligand pharmaceuticals.
Hurst RE
Curr Opin Investig Drugs; 2000 Dec; 1(4):514-23. PubMed ID: 11249708
[TBL] [Abstract][Full Text] [Related]
43. The retinoid X receptor: a nuclear receptor that modulates the sleep-wake cycle in rats.
Murillo-Rodríguez E; Millán-Aldaco D; Arankowsky-Sandoval G; Yamamoto T; Cid L; Monteiro D; Rocha NB; Telles-Correia D; Teixeira DS; Veras AB; Budde H; Machado S; Imperatori C; Torterolo P
Psychopharmacology (Berl); 2020 Jul; 237(7):2055-2073. PubMed ID: 32472163
[TBL] [Abstract][Full Text] [Related]
44. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
45. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
Mirza Z; Beg MA
Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
[TBL] [Abstract][Full Text] [Related]
46. Retinoid X receptor-mediated neuroprotection via CYP19 upregulation and subsequent increases in estradiol synthesis.
Ishihara Y; Sakurai H; Oguro A; Tsuji M; Vogel CFA; Yamazaki T
J Steroid Biochem Mol Biol; 2019 Oct; 193():105421. PubMed ID: 31265900
[TBL] [Abstract][Full Text] [Related]
47. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
[TBL] [Abstract][Full Text] [Related]
48. RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.
Nam KN; Mounier A; Fitz NF; Wolfe C; Schug J; Lefterov I; Koldamova R
Sci Rep; 2016 Apr; 6():24048. PubMed ID: 27051978
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of cutaneous T-cell lymphoma with retinoid receptor X-selective ligands: endocrine and metabolic disorders].
Avilés Pérez MD; Luna López V; Rodríguez Nevado I; de Argila Fernández-Durán D; Díaz Pérez de Madrid J
An Med Interna; 2007 Dec; 24(12):595-8. PubMed ID: 18278999
[TBL] [Abstract][Full Text] [Related]
50. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R
Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899
[TBL] [Abstract][Full Text] [Related]
51. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.
Certo M; Endo Y; Ohta K; Sakurada S; Bagetta G; Amantea D
Pharmacol Res; 2015 Dec; 102():298-307. PubMed ID: 26546745
[TBL] [Abstract][Full Text] [Related]
52. Ligand-bound RXR can mediate retinoid signal transduction during embryogenesis.
Lu HC; Eichele G; Thaller C
Development; 1997 Jan; 124(1):195-203. PubMed ID: 9006080
[TBL] [Abstract][Full Text] [Related]
53. Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression.
Volakakis N; Tiklova K; Decressac M; Papathanou M; Mattsson B; Gillberg L; Nobre A; Björklund A; Perlmann T
J Neurosci; 2015 Oct; 35(42):14370-85. PubMed ID: 26490873
[TBL] [Abstract][Full Text] [Related]
54. Preclinical PET Neuroimaging of [11C]Bexarotene.
Rotstein BH; Placzek MS; Krishnan HS; Pekošak A; Collier TL; Wang C; Liang SH; Burstein ES; Hooker JM; Vasdev N
Mol Imaging; 2016; 15():. PubMed ID: 27553293
[TBL] [Abstract][Full Text] [Related]
55. The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation
Gaunt CM; Rainbow DB; Mackenzie RJ; Jarvis LB; Mousa HS; Cunniffe N; Georgieva Z; Brown JW; Coles AJ; Jones JL
Front Immunol; 2021; 12():712241. PubMed ID: 34447379
[TBL] [Abstract][Full Text] [Related]
56. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cesario RM; Stone J; Yen WC; Bissonnette RP; Lamph WW
Cancer Lett; 2006 Aug; 240(2):225-33. PubMed ID: 16271436
[TBL] [Abstract][Full Text] [Related]
57. Oral bexarotene in the treatment of cutaneous T-cell lymphoma.
Wong SF
Ann Pharmacother; 2001 Sep; 35(9):1056-65. PubMed ID: 11573857
[TBL] [Abstract][Full Text] [Related]
58. Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.
Lin JH; Kim EJ; Bansal A; Seykora J; Richardson SK; Cha XY; Zafar S; Nasta S; Wysocka M; Benoit B; Rook AH; Fakharzadeh SS
Blood; 2008 Sep; 112(6):2484-8. PubMed ID: 18559673
[TBL] [Abstract][Full Text] [Related]
59. Retinoids stimulate fibrinogen production both in vitro (hepatocytes) and in vivo. Induction requires activation of the retinoid X receptor.
Nicodeme E; Nicaud M; Issandou M
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1660-7. PubMed ID: 7583541
[TBL] [Abstract][Full Text] [Related]
60. Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors.
Chitranshi N; Dheer Y; Kumar S; Graham SL; Gupta V
J Cell Biochem; 2019 Jul; 120(7):11745-11760. PubMed ID: 30746761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
